Real-world use of tisagenlecleucel in children and young adults with relapsed or refractory B-cell lymphomas.
Bender JD, Damodharan S, Capitini CM, Moskop A, Toner K, Vatsayan A, Talano JA, Baggott C, Schiff D, Katsanis E, Modi AJ, Quigg TC, Raikar SS, Schultz LM, Pommert L.
Bender JD, et al.
Blood Adv. 2024 Aug 13;8(15):4164-4168. doi: 10.1182/bloodadvances.2024012928.
Blood Adv. 2024.
PMID: 38916857
Free PMC article.
No abstract available.